Neurophysiological biomarkers to optimize deep brain stimulation in movement disorders

Neurodegener Dis Manag. 2021 Aug;11(4):315-328. doi: 10.2217/nmt-2021-0002. Epub 2021 Jul 15.

Abstract

Intraoperative neurophysiological information could increase accuracy of surgical deep brain stimulation (DBS) lead placement. Subsequently, DBS therapy could be optimized by specifically targeting pathological activity. In Parkinson's disease, local field potentials (LFPs) excessively synchronized in the beta band (13-35 Hz) correlate with akinetic-rigid symptoms and their response to DBS therapy, particularly low beta band suppression (13-20 Hz) and high frequency gamma facilitation (35-250 Hz). In dystonia, LFPs abnormally synchronize in the theta/alpha (4-13 Hz), beta and gamma (60-90 Hz) bands. Phasic dystonic symptoms and their response to DBS correlate with changes in theta/alpha synchronization. In essential tremor, LFPs excessively synchronize in the theta/alpha and beta bands. Adaptive DBS systems will individualize pathological characteristics of neurophysiological signals to automatically deliver therapeutic DBS pulses of specific spatial and temporal parameters.

Keywords: Parkinson’s disease; deep brain stimulation; dystonia; essential tremor; local field potentials; microelectrode recordings; neuromodulation; neurophysiological biomarkers.

Publication types

  • Review

MeSH terms

  • Biomarkers*
  • Deep Brain Stimulation / methods*
  • Dystonia / therapy*
  • Humans
  • Movement Disorders / therapy
  • Parkinson Disease / therapy*

Substances

  • Biomarkers